Vaughn Himes - Seattle Genetics Insider

SGEN -- USA Stock  

USD 68.03  0.09  0.13%

Executive VP of Process Sciences and Technical Operations
Dr. Vaughn B. Himes, Ph.D. serves as Chief Technical Officer of the Company. He was Executive Vice President Technical Operations and Process Sciences of Seattle Genetics, Inc. Dr. Himes joined Seattle Genetics as Executive Vice President, Technical Operations in April 2009 and has served as our Executive Vice President, Technical Operations and Process Science since July 2012. Previously, Dr. Himes was with ZymoGenetics, Inc. from November 2005 to March 2009, most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. From March 2003 to October 2005, he was Vice President, Manufacturing at Corixa, Inc. Prior to that, he held Vice President positions in manufacturing and development at Targeted Genetics and Genovo
Age: 55  EVP Since 2016  Ph.D    
Himes received a Bachelor of Arts in Chemistry from Pomona College in California and a Ph.D. in Chemical Engineering from the University of Minnesota.

Vaughn Himes Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (12.28) % which means that it has lost $12.28 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (18.83) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 1 records

EVP Since

Stuart ArbuckleVertex Pharmaceuticals Incorpor

Entity Summary

Seattle Genetics, Inc., a biotechnology company, focuses on the development and commercialization of targeted therapies for the treatment of cancer worldwide. Seattle Genetics, Inc. was founded in 1998 and is headquartered in Bothell, Washington. Seattle Genetics operates under Biotechnology classification in USA and traded on NASDAQ. It employs 1100 people.Seattle Genetics (SGEN) is traded on NASDAQ in USA. It is located in 21823 30th Drive SE and employs 1,100 people.

Seattle Genetics Leadership Team

Pinkston Peggy, Director
David Gryska, Director, MBA
Vaughn Himes, EVP, Ph.D
Daniel Welch, Director, MBA
Felix Baker, Director, Ph.D
Srinivas Akkaraju, Director, Ph.D
Alpna Seth, Director
Nancy Simonian, Director, Ph.D
Marc Lippman, Director
Peggy Pinkston, Executive
Jonathan Drachman, President
Jean Liu, President
Robert Lechleider, President, Ph.D
Clay Siegall, Chairman, Ph.D
Darren Cline, President, MBA
Dennis Benjamin, President, Ph.D
Eric Dobmeier, COO
John Orwin, Director, MBA
Todd Simpson, CFO
John McLaughlin, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Center Now

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Portfolio Center
Currently Active Assets on Macroaxis
Purchased few shares of
few hours ago
Traded for 79.19
Purchased few shares of
few hours ago
Traded for 179.93
Purchased few shares of
few hours ago
Traded for 281.04
Sold one share of
few hours ago
Traded for 42.84
Purchased over 90 shares of
few hours ago
Traded for 45.12
Also please take a look at World Market Map. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.